Amgen Inc. (AMGN)
NASDAQ
Healthcare
Drug Manufacturers - General
$344.72
▲ +2.11%
Market Cap
$186.05B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.42
52-Wk Range
269.01-391.29
CEO
Robert A. Bradway
Country
US
Currency
USD
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthri…
Open full interactive analysis & DCF →